Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease.

Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease.

http://www.wikidata.org/entity/Q32091544

about

Quantitative magnetic resonance imaging traits as endophenotypes for genetic mapping in epilepsy Neuroanatomic substrates of late-life mental disorders.Magnetic resonance imaging and magnetic resonance spectroscopy in dementias Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease.Imaging studies and APOE genotype in persons at risk for Alzheimer's disease.Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham Study.APOE Affects the Volume and Shape of the Amygdala and the Hippocampus in Mild Cognitive Impairment and Alzheimer's Disease: Age Matters Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study.Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment.Visceral fat is associated with lower brain volume in healthy middle-aged adults.Mapping the Alzheimer's brain with connectomics.A four-dimensional probabilistic atlas of the human brain.APOE-dependent PET patterns of brain activation in Alzheimer disease.Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.Dissecting the gene dose-effects of the APOE ε4 and ε2 alleles on hippocampal volumes in aging and Alzheimer's disease Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phase.Family history of Alzheimer's disease and hippocampal structure in healthy people.Longitudinal changes in medial temporal cortical thickness in normal subjects with the APOE-4 polymorphism.Influence of brain-derived neurotrophic factor and apolipoprotein E genetic variants on hemispheric and lateral ventricular volume of young healthy adults.Neuropsychological deficits associated with Alzheimer's disease in the very-old: discrepancies in raw vs. standardized scores.Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment.Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan.Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span.Age effects on atrophy rates of entorhinal cortex and hippocampus Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease in Two Independent Cohorts.Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease.The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story.Effect of intellectual enrichment on AD biomarker trajectories: Longitudinal imaging study.Selective effect of Apo e4 on CA3 and dentate in normal aging and Alzheimer's disease using high resolution MRI at 4 T.Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease.APOE related hippocampal shape alteration in geriatric depression.Rates of hippocampal atrophy correlate with change in clinical status in aging and AD.Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI.APOE ε4 worsens hippocampal CA1 apical neuropil atrophy and episodic memory.

P2860

Q28067109-3D31EB68-1E92-41A7-8A1B-035AB9CDB5AA Q30585266-BFD9352A-30BB-4E21-A555-EE13EE27C47A Q30660816-B9A66B9D-8E25-4D23-861A-2B157B0E1258 Q30983010-2397FF63-D14C-4F27-9B57-60F2719BF570 Q31033399-9D2C0EDB-6B83-410F-887A-3E3F68B3AEA4 Q33300810-4A899FD8-DEE4-4568-96FB-89579068A4D2 Q33822745-27C3476A-0189-43C4-851C-3BCF97FC9D85 Q33917722-066BD2D4-AF59-459B-BD72-6FF907419C5F Q33933382-D6BCE678-545E-4FC2-9940-9FBB6262F72A Q33941672-D533CD00-489F-4E68-B449-79CA63834A3F Q34004321-1F2D4C09-87EF-4952-BF4E-B6419CC94E42 Q34105185-46CA51BD-03C7-458A-B46E-5C814AE6C925 Q34145777-205965A5-EF0E-489D-9AEA-A6245026236F Q34205705-96E4BC63-FA55-4EFD-B00C-1EF04F8E48C9 Q34518956-6B15C849-5FD4-4AC6-B8CF-B1EB78472F0B Q34570703-495A2208-A7AE-4F95-8A89-EEFD016B966A Q34583924-ADDD0585-733E-4BBA-A527-E2744502A9DB Q34636326-A649AF75-3095-4D89-9D3D-777DEE5A6624 Q34907217-EB82860C-A830-42C4-B90B-8A0E11BC5F3B Q35055317-5FAACF5B-B061-411B-B05C-B3236EFA3CA3 Q35058421-99F3B82F-4EA5-4804-A84F-B4D4E76E3695 Q35107338-DE2E0B9F-7894-4DAD-8CD4-0B4F9A549687 Q35224265-51FB75E4-D469-4F59-84BF-40009B32AE1C Q35229601-2036F252-23D3-4839-95AB-93ADB385C234 Q35598271-63E43695-28FB-4753-B23C-69BB0E2435AB Q35606365-1077A1E1-C648-4CA3-95C9-CB1B24DD4402 Q35930847-A72AE7B2-6E5A-4679-BE89-71D9E2D750F0 Q36044934-348FFF17-3562-4AC8-BA8F-B0EECE36FE1A Q36075642-59A7FF37-B77F-4158-87B2-2CBFCA4DC3C5 Q36475090-57B3F16D-BF1C-4A46-8FDC-E6DE6F91B693 Q36763368-56804E6D-CAFC-4129-8B17-E7DB69EB1791 Q37002807-B991D923-CDB8-4D98-8C6D-5E8FD2003EBB Q37098909-132DC323-70BD-4F0B-894C-C43C55D58FBF Q37111603-BC7136D7-8E40-40BD-BB28-312038CB23F8 Q37299819-D7D853A3-87D3-4DF2-B46C-783398F2F9C1 Q37300216-B9FB3F2F-5AE3-4799-87F8-15D75E304524 Q37313783-CBF8350C-F462-4339-8520-60C891086639 Q37337930-68117C41-1E48-4A12-B1F7-7B7209086432 Q37402321-AC9E2955-B261-41EF-8B67-20D3488D115D Q37623222-A14E0BAE-2F49-48B6-97B1-4772BF4B1008

P2860

Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease.

http://www.wikidata.org/entity/Q32091544

description

1998 nî lūn-bûn

@nan

1998 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի մարտին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Hippocampal atrophy and apolip ...... ated with Alzheimer's disease.

@ast

Hippocampal atrophy and apolip ...... ated with Alzheimer's disease.

@en

type

label

Hippocampal atrophy and apolip ...... ated with Alzheimer's disease.

@ast

Hippocampal atrophy and apolip ...... ated with Alzheimer's disease.

@en

prefLabel

Hippocampal atrophy and apolip ...... ated with Alzheimer's disease.

@ast

Hippocampal atrophy and apolip ...... ated with Alzheimer's disease.

@en

P1433

Q32091544-87A06CDA-93DE-4F22-BFD2-DEF08B6A83E0

P1476

Q32091544-B0782564-C839-47DB-A9DB-550D3F0EF432

P2093

Q32091544-2569496A-8182-4D8D-9C26-D3D95DA52037

Q32091544-344C6D6E-48FA-42B0-A3A8-DB1FADDC5C1E

Q32091544-6693BC10-0374-4720-877A-35BD2AEAA0D4

Q32091544-69237F3D-F700-4B0D-82AE-BCB0046EC8E4

Q32091544-6BAF1434-5C70-4F74-8734-53A1357E0185

Q32091544-7103BEEA-E782-4C16-BC52-4F53DB374AA9

Q32091544-CB854B19-9903-433C-BFF6-581E91194F46

Q32091544-F87A3B90-047F-49F6-A946-52F58A23CB8C

Q32091544-F949C5F6-147A-4293-94AD-DE71DBAE65F5

P2860

Q32091544-011465FB-C084-429B-9F8A-E8841F628925

Q32091544-079E0392-3D08-42D2-94EF-6696BE2F6375

Q32091544-09D6D67B-C174-421B-A95C-AABBC33284D8

Q32091544-0DF9BEB3-7608-40EA-AE5D-616305F2EABF

Q32091544-159BA3BC-F542-4A72-852E-A408586E19B8

Q32091544-1B757643-0012-48B3-AE19-409C7AE7CE81

Q32091544-2040B30D-D00C-4058-A306-2500E3319F83

Q32091544-26E974E6-9E2C-4ED9-A4D4-E4ECE33AAE1B

Q32091544-2B502BB7-2576-468A-AC94-813B5A5E95A3

Q32091544-2FBAF724-1CC5-4388-8307-B81A65213AA8

P304

Q32091544-F9FDB7BF-EDD0-4E48-9C78-596586AD9A21

P31

Q32091544-26F66D1C-1302-451D-843E-AF39BB3F0086

P356

Q32091544-18E78DD6-67FC-4D53-B3EB-2C2EF0EEB146

P433

Q32091544-560DA0B9-A501-4FBC-AA94-BE9B73029BA5

P478

Q32091544-8133B554-7846-4D2E-ACC5-6FAD9FBE2C8F

P50

Q32091544-464B7925-B965-4A29-9F1D-B3FD771CECF7

P577

Q32091544-CBBA9DBF-CBA4-48BE-BED3-E41317EABC88

P5875

Q32091544-B8935C78-B655-4CEB-AB60-99E5CF0F64E6

P698

Q32091544-7CB3E136-68CA-4509-B871-7C0B7D79949C

P932

Q32091544-9FE7EF3C-B0EB-4929-A737-47324F37D22E

P356

P1433

Annals of Neurology

P1476

Hippocampal atrophy and apolip ...... iated with Alzheimer's disease

@en

P2093

C R Jack

http://www.w3.org/2001/XMLSchema#string

E G Tangalos

http://www.w3.org/2001/XMLSchema#string

E Kokmen

http://www.w3.org/2001/XMLSchema#string

P C O'Brien

http://www.w3.org/2001/XMLSchema#string

R C Petersen

http://www.w3.org/2001/XMLSchema#string

R J Ivnik

http://www.w3.org/2001/XMLSchema#string

S C Waring

http://www.w3.org/2001/XMLSchema#string

S N Thibodeau

http://www.w3.org/2001/XMLSchema#string

Y C Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

“Mini-mental state”

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neuropathological stageing of Alzheimer-related changes

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

The Clinical Dementia Rating (CDR): current version and scoring rules

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.

SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele.

P304

303-310

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.410430307

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

P577

1998-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51303968

http://www.w3.org/2001/XMLSchema#string

P698

9506546

http://www.w3.org/2001/XMLSchema#string

P932

2752747

http://www.w3.org/2001/XMLSchema#string